MedTrace Logo

Satiety, Glycemic, and Gastrointestinal Effects of Novel Fibers

NCT00958399 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2012-02-06

No results posted yet for this study

Summary

Research suggests dietary fiber may play a role in weight management, and fiber consumption is inversely associated with body weight, body fat, and BMI in cross-sectional studies. These effects may be mediated by increased satiety, reduced food intake, or changes in blood levels of glucose, insulin, and gut hormones.

The purpose of this study is to determine the satiety, glycemic, hormonal, and gastrointestinal responses of novel fiber supplements.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Placebo

Low fiber muffin, hot cereal and beverage (acute phase) or fiber bars and beverage (chronic phase)

DIETARY_SUPPLEMENT

Resistant Starch

25 g resistant starch, administered in a muffin, hot cereal and beverage (acute phase) or fiber bars and beverage (chronic phase)

DIETARY_SUPPLEMENT

Resistant starch + soluble fiber

25 g fiber as resistant starch and a soluble fiber, administered in a muffin, hot cereal and beverage (acute phase) or fiber bars and beverage (chronic phase)

DIETARY_SUPPLEMENT

Fiber made from corn starch

25 g fiber made from corn starch, administered in a muffin, hot cereal and beverage (acute phase) or fiber bars and beverage (chronic phase)

DIETARY_SUPPLEMENT

Fiber made from corn starch + soluble fiber

25 g fiber as a fiber made from corn starch and a soluble fiber, administered in a muffin, hot cereal and beverage (acute phase) or fiber bars and beverage (chronic phase)

Sponsors & Collaborators

Principal Investigators

  • Joanne L Slavin, PhD · University of Minnesota

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2009-04-30
Completion
2010-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00958399 on ClinicalTrials.gov